TY - JOUR
T1 - Sepsis
T2 - deriving biological meaning and clinical applications from high-dimensional data
AU - Schuurman, Alex R
AU - Reijnders, Tom D Y
AU - Kullberg, Robert F J
AU - Butler, Joe M
AU - van der Poll, Tom
AU - Wiersinga, W Joost
PY - 2021/5/7
Y1 - 2021/5/7
N2 - The pathophysiology of sepsis is multi-facetted and highly complex. As sepsis is a leading cause of global mortality that still lacks targeted therapies, increased understanding of its pathogenesis is vital for improving clinical care and outcomes. An increasing number of investigations seeks to unravel the complexity of sepsis through high-dimensional data analysis, enabled by advances in -omics technologies. Here, we summarize progress in the following major -omics fields: genomics, epigenomics, transcriptomics, proteomics, lipidomics, and microbiomics. We describe what these fields can teach us about sepsis, and highlight current trends and future challenges. Finally, we focus on multi-omics integration, and discuss the challenges in deriving biological meaning and clinical applications from these types of data.
AB - The pathophysiology of sepsis is multi-facetted and highly complex. As sepsis is a leading cause of global mortality that still lacks targeted therapies, increased understanding of its pathogenesis is vital for improving clinical care and outcomes. An increasing number of investigations seeks to unravel the complexity of sepsis through high-dimensional data analysis, enabled by advances in -omics technologies. Here, we summarize progress in the following major -omics fields: genomics, epigenomics, transcriptomics, proteomics, lipidomics, and microbiomics. We describe what these fields can teach us about sepsis, and highlight current trends and future challenges. Finally, we focus on multi-omics integration, and discuss the challenges in deriving biological meaning and clinical applications from these types of data.
U2 - https://doi.org/10.1186/s40635-021-00383-x
DO - https://doi.org/10.1186/s40635-021-00383-x
M3 - Review article
C2 - 33961170
SN - 2197-425X
VL - 9
SP - 27
JO - Intensive Care Medicine Experimental
JF - Intensive Care Medicine Experimental
IS - 1
ER -